| __timestamp | Axsome Therapeutics, Inc. | Catalyst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 10117774 |
| Thursday, January 1, 2015 | 6776987 | 11801342 |
| Friday, January 1, 2016 | 21199860 | 11369941 |
| Sunday, January 1, 2017 | 19957616 | 11375237 |
| Monday, January 1, 2018 | 23495055 | 19919204 |
| Tuesday, January 1, 2019 | 53647067 | 18842752 |
| Wednesday, January 1, 2020 | 70244579 | 16496715 |
| Friday, January 1, 2021 | 58060725 | 16936000 |
| Saturday, January 1, 2022 | 57947447 | 19789000 |
| Sunday, January 1, 2023 | 97944000 | 93150000 |
| Monday, January 1, 2024 | 187077000 |
Unleashing the power of data
In the ever-evolving world of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Axsome Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc. have demonstrated significant commitment to R&D, with Axsome's spending surging by over 2,000% from 2014 to 2023. This remarkable growth underscores the company's dedication to pioneering treatments. Meanwhile, Catalyst Pharmaceuticals has maintained a steady investment, with a notable spike in 2023, where R&D expenses nearly quadrupled compared to previous years. This trend highlights the industry's dynamic nature, where strategic R&D investments can lead to groundbreaking therapies. As these companies continue to push the boundaries of medical science, their R&D efforts not only drive their growth but also promise to deliver transformative healthcare solutions.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
R&D Insights: How Gilead Sciences, Inc. and Axsome Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Zoetis Inc. vs Axsome Therapeutics, Inc.
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Axsome Therapeutics, Inc.
Research and Development Investment: Viatris Inc. vs Axsome Therapeutics, Inc.
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Grifols, S.A. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.